HAIXI PHARMA will delay its market launch

Zhitong
2025.10.16 13:29
portai
I'm PortAI, I can summarize articles.

According to the Zhitong Finance APP, HAIXI PHARMA announced that due to the need for additional time to finalize the distribution results announcement and obtain regulatory approval, the company's listing schedule will be postponed. The board of directors will provide the latest information to the market as soon as practicable

According to the Zhitong Finance APP, HAIXI PHARMA (02637) announced that due to the need for additional time to finalize the distribution results announcement and obtain regulatory approval, the company's listing schedule will be postponed. The board of directors will provide the latest information to the market as soon as practicable

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.